Profile
Alan Cherrington is the founder of Abvance Therapeutics, Inc. founded in 2016.
Dr. Cherrington is currently a Professor at Vanderbilt University.
Former positions include Director at Protemix Corp.
Ltd. and President at American Diabetes Association.
Alan Cherrington active positions
| Companies | Position | Start |
|---|---|---|
Vanderbilt University
Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 25/03/2009 |
Former positions of Alan Cherrington
| Companies | Position | End |
|---|---|---|
Protemix Corp. Ltd.
Protemix Corp. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Board Member | 13/07/2011 |
Abvance Therapeutics, Inc.
Abvance Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company developing insulin | Founder | - |
American Diabetes Association
American Diabetes Association Miscellaneous Commercial ServicesCommercial Services Provides diabetes related medical services | President | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Protemix Corp. Ltd.
Protemix Corp. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Vanderbilt University
Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Diabetes Association
American Diabetes Association Miscellaneous Commercial ServicesCommercial Services Provides diabetes related medical services | Commercial Services |
Abvance Therapeutics, Inc.
Abvance Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company developing insulin | Health Technology |
- Stock Market
- Insiders
- Alan Cherrington
















